About the Company
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CBIO News
Seline E. Miller's Net Worth
This is based on reported shares across multiple companies, which include Rezolute, Inc., and CATALYST BIOSCIENCES, INC..
Catalyst Acoustics Group Acquires Madrid, Inc., Expanding Portfolio
Press Release Catalyst Acoustics Group, Inc. ("Catalyst Acoustics Group" or "CAG"), a portfolio company of The Stephens Group, LLC ("Stephens Group") and a platform for an elite group of acoustic, ...
Milestone Scientific Stock (AMEX:MLSS), Quotes and News Summary
Howmet Aerospace shares fell 0.1% to close at $45.98 on Friday. Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has ...
Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it was selected as a spoke for the Investor Catalyst Hub ...
Sagimet Biosciences Inc. (SGMT)
May 07, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet ... its participation in the First Annual Goldman Sachs Catalyst Clinic. Management is scheduled to participate in a virtual ...
Artelo Biosciences: Strong Buy Rating on Clinical Advancement and Solid Financials
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Artelo Biosciences (ARTL – Research ...
Daré Bioscience, Inc. (DARE)
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide ...
Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value
Caribou Biosciences, Inc. (NASDAQ:CRBU ... of this program would be two catalysts in particular. The first catalyst would be the presentation of phase 1 ANTLER trial data at an upcoming medical ...
Loading the latest forecasts...